Results 71 to 80 of about 720 (123)

"The Computer as a Sophisticated Disguise of the Devil" : Supposed Technophobia in German-Speaking Protestant Churches towards Electronic Data Processing (EDP). [PDF]

NTM
Meyer J.
europepmc   +1 more source

Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses. [PDF]

Sci Transl Med
Ling AL, Gantchev J, Prabhu MC, Basu S, Ahn R, D'Souza A, Masud N, Ball A, Nikas O, Villa GR, Regan MS, Baquer G, Ayoub G, Whittaker CA, Abou-Mrad Z, Santos A, Couturier CP, Elharouni D, Vogelzang J, Yu KKH, Chen H, He Z, Jiang W, Lucas CH, Sax HE, Lang FF, Puduvalli VK, Tabar V, W Brennan C, Boire A, Holdhoff M, Bettegowda C, Cima M, Solomon IH, Yuan Y, Tak PP, Accelerating GBM Therapies TeamLab, Sharma P, White FM, Ligon KL, Agar NYR, Reardon DA, Oliveira G, Chiocca EA.   +43 more
europepmc   +1 more source

Identification of Stochastically Perturbed Autonomous Systems from Temporal Sequences of Probability Density Functions. [PDF]

J Nonlinear Sci, 2018
Nie X, Luo J, Coca D, Birkin M, Chen J.
europepmc   +1 more source

CD8⁺CD161⁺ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential. [PDF]

Front Immunol, 2020
Konduri V, Oyewole-Said D, Vazquez-Perez J, Weldon SA, Halpert MM, Levitt JM, Decker WK.   +6 more
europepmc   +1 more source

A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer. [PDF]

Oncologist
Viniotis AF, Jameson GS, Wertheim BC, Roe DJ, Lee K, Tsai FY, Gordon MS, Sharma S, Guarnieri CM, Snyder CE, Thosani AJ, Amini A, Sckolnik SE, Garrick JM, Korn RL, Rahmanuddin S, Evans RM, Downes M, Truitt M, Von Hoff DD, Borazanci EH.   +20 more
europepmc   +1 more source

Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types. [PDF]

Front Immunol, 2020
Oyewole-Said D, Konduri V, Vazquez-Perez J, Weldon SA, Levitt JM, Decker WK.   +5 more
europepmc   +1 more source

Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial. [PDF]

Nat Med
Musher BL, Vasileiou S, Smaglo BG, Robertson CS, Wu M, Wang T, Watanabe A, Kuvalekar M, Velazquez Y, Ketkar S, Doheyan TA, Papayanni PG, Shah A, Lapteva N, Grilley BJ, Van Buren G, Lulla PD, Heslop HE, Rooney CM, Brenner MK, Leen AM.   +20 more
europepmc   +1 more source

Bridging Waves and Crucial Events in the Dynamics of the Brain. [PDF]

Front Physiol, 2018
Bohara G, West BJ, Grigolini P.
europepmc   +1 more source

MHC class I and II peptide homology regulates the cellular immune response. [PDF]

FASEB J, 2020
Halpert MM, Konduri V, Liang D, Vazquez-Perez J, Hofferek CJ, Weldon SA, Baig Y, Vedula I, Levitt JM, Decker WK.   +9 more
europepmc   +1 more source

The promising cancer treatment approach in cancer immunotherapy: dendritic cell-based vaccines. [PDF]

Front Immunol
Wang J, Jia X, Zhang Y, Wang X, Fu Y, He Z.   +5 more
europepmc   +1 more source